感染症体外診断市場のシェア・規模・動向・産業分析・予測 (2022年～2030年)：製品 (機器・試薬・ソフトウェア)・用途 (MRSA・VRE・連鎖球菌)・技術・エンドユーザー・地域別

世界の感染症体外診断の市場規模は2030年には628億3,000万米ドルの規模に成長すると予測されています。

当レポートでは、世界の感染症体外診断の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の感染症体外診断市場の洞察

• 感染症体外診断：産業のスナップショット
• 感染症体外診断：市場力学
  • 成長推進因子・機会
  • 成長抑制因子・課題
• ポーターのファイブフォース分析
• PESTLE分析
• 感染症体外診断産業の動向
• バリューチェーン分析
• COVID-19：影響分析

第5章 世界の感染症体外診断市場：用途別

• 主な調査結果
• MRSA
• VRE
• CRE
• クロストリジウムディフィシル
• 連鎖球菌

第6章 世界の感染症体外診断市場：製品別

• 主な調査結果
• 機器
• 試薬
• ソフトウェア

第7章 世界の感染症体外診断市場：技術別

• 主な調査結果
• イムノアッセイ
• 分子診断
• 微生物
• その他

第8章 世界の感染症体外診断市場：エンドユーザー別

• 主な調査結果
• 病院・診療所
• 診断ラボ
• 学術研究機関
• その他

第9章 世界の感染症体外診断市場：地域別

• 主な調査結果
• 北米
• 欧州
• アジア太平洋
• 中東・アフリカ
• ラテンアメリカ

第10章 競合情勢

• 拡張・買収の分析
• 提携・協力・合意・展示会

第11章 企業プロファイル

• Abbott Laboratories
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc
• Danaher Corporation
• DiaSorin
• F. Hoffmann-La Roche AG
• Hologic, Inc
• Illumina, Inc.
• InBios International, Inc
• Koninklijke Philips N.V
• Laboratory Corporation of America Holdings
• Merck KGaA
• OraSure Technologies, Inc.
• PerkinElmer, Inc
• Qiagen N.V
• Quest Diagnostics
• Quidel Corporation
• Siemens Healthcare AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc

List of Tables

• Table 1 Global Infectious Disease In Vitro Diagnostics Market, by Application, by Region, 2018 - 2030 (USD Billion)
• Table 2 Global Infectious Disease In Vitro Diagnostics Market, by Product, by Region, 2018 - 2030 (USD Billion)
• Table 3 Global Infectious Disease In Vitro Diagnostics Market, by Technology, by Region, 2018 - 2030 (USD Billion)
• Table 4 Global Infectious Disease In Vitro Diagnostics Market, by End-Use, by Region, 2018 - 2030 (USD Billion)
• Table 5 Infectious Disease In Vitro Diagnostics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
• Table 6 North America: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 7 North America: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 8 North America: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 9 North America: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 10 U.S.: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 11 U.S.: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 12 U.S.: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 13 U.S.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 14 Canada: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 15 Canada: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 16 Canada: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 17 Canada: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 18 Europe: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 19 Europe: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 20 Europe: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 21 Europe: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 22 Germany: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 23 Germany: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 24 Germany: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 25 Germany: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 26 France: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 27 France: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 28 France: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 29 France: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 30 UK: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 31 UK: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 32 UK: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 33 UK: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 34 Italy: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 35 Italy: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 36 Italy: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 37 Italy: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 38 Netherlands: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 39 Netherlands: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 40 Netherlands: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 41 Netherlands: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 42 Spain: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 43 Spain: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 44 Spain: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 45 Spain: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 46 Russia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 47 Russia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 48 Russia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 49 Russia: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 50 Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 51 Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 52 Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 53 Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 54 China: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 55 China: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 56 China: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 57 China: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 58 Japan: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 59 Japan: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 60 Japan: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 61 Japan: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 62 India: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 63 India: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 64 India: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 65 India: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 66 Indonesia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 67 Indonesia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 68 Indonesia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 69 Indonesia: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 70 Malaysia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 71 Malaysia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 72 Malaysia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 73 Malaysia: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 74 South Korea: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 75 South Korea: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 76 South Korea: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 77 South Korea: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 78 Latin America: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 79 Latin America: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 80 Latin America: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 81 Latin America: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 82 Brazil: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 83 Brazil: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 84 Brazil: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 85 Brazil: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 86 Mexico: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 87 Mexico: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 88 Mexico: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 89 Mexico: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 90 Argentina: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 91 Argentina: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 92 Argentina: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 93 Argentina: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 94 Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 95 Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 96 Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 97 Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 98 UAE: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 99 UAE: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 100 UAE: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 101 UAE: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 102 Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 103 Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 104 Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 105 Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 106 South Africa: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 107 South Africa: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 108 South Africa: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 109 South Africa: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• Table 110 Israel: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• Table 111 Israel: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• Table 112 Israel: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• Table 113 Israel: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Infectious Disease In Vitro Diagnostics Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up End-Use

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Application

Figure 7. Global Infectious Disease In Vitro Diagnostics Market, by Application, 2021 & 2030 (USD Billion)

Figure 8. Market by End-Use

Figure 9. Global Infectious Disease In Vitro Diagnostics Market, by End-Use, 2021 & 2030 (USD Billion)

Figure 10. Market by Product

Figure 11. Global Infectious Disease In Vitro Diagnostics Market, by Product, 2021 & 2030 (USD Billion)

Figure 12. Market by Technology

Figure 13. Global Infectious Disease In Vitro Diagnostics Market, by Technology, 2021 & 2030 (USD Billion)

Figure 14. Infectious Disease In Vitro Diagnostics Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Infectious Disease In Vitro Diagnostics Market

The global Infectious Disease In Vitro Diagnostics market size is expected to reach USD 62.83 billion by 2030, according to a new study by Polaris Market Research. The report "Infectious Disease In Vitro Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents, Software); By Application (MRSA, VRE, Streptococcus); By Technology; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides an analysis of future market growth.

The growing infectious diseases across the globe, people's awareness, and technological adoption are the drivers for the IVD test. Furthermore, COVID-19 tests, the increasing geriatric population, and user-friendly devices with low cost and high efficiency are the major factors driving demand.

In addition, the growing geriatric population & spread of acute as well as chronic diseases across developing economies such as India, Japan, and China is likely to positively impact the demand for IVD devices over the coming years. However, the increase in disease will increase the number of tests over the forecasting period.

The COVID-19 pandemic has positively affected the expansion of the market, as the detection of the COVID test was mandatory, whether positive or negative. The emergence of the COVID-19 increased awareness among people, increasing regular health checkup tests. It is estimated that the market will keep rising over the forecasting period.

Infectious Disease In Vitro Diagnostics Market Report Highlights

Molecular diagnostics technology is increasing as it uses advanced technology with low cost, and better results.

The reagent segment accounted for the highest revenue share in 2021 and is expected to continue its dominance owing to many tests for detecting diseases and people's awareness.

Infectious diseases contributed a higher share of revenue owing to COVID-19 testing globally. The conditions are spreading widely, thus resulting in the number of tests for infectious diseases like tuberculosis, heart disease, and oncology will keep increasing, thus helping to cure and diagnose.

Asia Pacific is anticipated to grow at a significant CAGR over the forecast period because of technological advancement, people's health awareness, and the increasing geriatric population across developing nations in the region, such as India and Japan.

Major players operating in the industry include Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin, F. Hoffmann-La Roche AG, Hologic, Inc., Illumina, Inc., InBios International, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Merck KGaA, OraSure Technologies, Inc., Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the Infectious Disease In Vitro Diagnostics market report based on Product, application, technology, end-use, and region:

Infectious Disease In Vitro Diagnostics, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Instruments

Reagents

Software

Infectious Disease In Vitro Diagnostics, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

Immunoassay

Molecular Diagnostics

Microbiology

Others

Infectious Disease In Vitro Diagnostics, Application Outlook (Revenue - USD Billion, 2018 - 2030)

MRSA

VRE

CRE

Clostridium Difficile

Streptococcus

Infectious Disease In Vitro Diagnostics, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals & Clinics

Diagnostic Laboratories

Academic Research Institutes

Others

Infectious Disease In Vitro Diagnostics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Infectious Disease In Vitro Diagnostics Market Insights

• 4.1. Infectious Disease In Vitro Diagnostics - Industry Snapshot
• 4.2. Infectious Disease In Vitro Diagnostics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing geriatric population
    • 4.2.1.2. Technological advancements
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High prices of IVD tests
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Infectious Disease In Vitro Diagnostics Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Infectious Disease In Vitro Diagnostics Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
• 5.3. MRSA
  • 5.3.1. Global Infectious Disease In Vitro Diagnostics Market, by MRSA, by Region, 2018 - 2030 (USD Billion)
• 5.4. VRE
  • 5.4.1. Global Infectious Disease In Vitro Diagnostics Market, by VRE, by Region, 2018 - 2030 (USD Billion)
• 5.5. CRE
  • 5.5.1. Global Infectious Disease In Vitro Diagnostics Market, by CRE, by Region, 2018 - 2030 (USD Billion)
• 5.6. Clostridium Difficile
  • 5.6.1. Global Infectious Disease In Vitro Diagnostics Market, by Clostridium Difficile, by Region, 2018 - 2030 (USD Billion)
• 5.7. Streptococcus
  • 5.7.1. Global Infectious Disease In Vitro Diagnostics Market, by Streptococcus, by Region, 2018 - 2030 (USD Billion)

6. Global Infectious Disease In Vitro Diagnostics Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
• 6.3. Instruments
  • 6.3.1. Global Infectious Disease In Vitro Diagnostics Market, by Instruments, by Region, 2018 - 2030 (USD Billion)
• 6.4. Reagents
  • 6.4.1. Global Infectious Disease In Vitro Diagnostics Market, by Reagents, by Region, 2018 - 2030 (USD Billion)
• 6.5. Software
  • 6.5.1. Global Infectious Disease In Vitro Diagnostics Market, by Software, by Region, 2018 - 2030 (USD Billion)

7. Global Infectious Disease In Vitro Diagnostics Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• 7.3. Immunoassay
  • 7.3.1. Global Infectious Disease In Vitro Diagnostics Market, by Immunoassay, by Region, 2018 - 2030 (USD Billion)
• 7.4. Molecular Diagnostics
  • 7.4.1. Global Infectious Disease In Vitro Diagnostics Market, by Molecular Diagnostics, by Region, 2018 - 2030 (USD Billion)
• 7.5. Microbiology
  • 7.5.1. Global Infectious Disease In Vitro Diagnostics Market, by Microbiology, by Region, 2018 - 2030 (USD Billion)
• 7.6. Others
  • 7.6.1. Global Infectious Disease In Vitro Diagnostics Market, by Others, by Region, 2018 - 2030 (USD Billion)

8. Global Infectious Disease In Vitro Diagnostics Market, by End-Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
• 8.3. Hospitals & Clinics
  • 8.3.1. Global Infectious Disease In Vitro Diagnostics Market, by Hospitals & Clinics, by Region, 2018 - 2030 (USD Billion)
• 8.4. Diagnostic Laboratories
  • 8.4.1. Global Infectious Disease In Vitro Diagnostics Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Billion)
• 8.5. Academic Research Institutes
  • 8.5.1. Global Infectious Disease In Vitro Diagnostics Market, by Academic Research Institutes, by Region, 2018 - 2030 (USD Billion)
• 8.6. Others
  • 8.6.1. Global Infectious Disease In Vitro Diagnostics Market, by Others, by Region, 2018 - 2030 (USD Billion)

9. Global Infectious Disease In Vitro Diagnostics Market, by Geography

• 9.1. Key findings
• 9.2. Introduction
  • 9.2.1. Infectious Disease In Vitro Diagnostics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
• 9.3. Infectious Disease In Vitro Diagnostics Market - North America
  • 9.3.1. North America: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
  • 9.3.2. North America: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 9.3.3. North America: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
  • 9.3.4. North America: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.3.5. Infectious Disease In Vitro Diagnostics Market - U.S.
    • 9.3.5.1. U.S.: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.3.5.2. U.S.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.3.5.3. U.S.: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.3.5.4. U.S.: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.3.6. Infectious Disease In Vitro Diagnostics Market - Canada
    • 9.3.6.1. Canada: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.3.6.2. Canada: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.3.6.3. Canada: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.3.6.4. Canada: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• 9.4. Infectious Disease In Vitro Diagnostics Market - Europe
  • 9.4.1. Europe: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
  • 9.4.2. Europe: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 9.4.3. Europe: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
  • 9.4.4. Europe: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.5. Infectious Disease In Vitro Diagnostics Market - UK
    • 9.4.5.1. UK: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.5.2. UK: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.5.3. UK: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.5.4. UK: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.6. Infectious Disease In Vitro Diagnostics Market - France
    • 9.4.6.1. France: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.6.2. France: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.6.3. France: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.6.4. France: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.7. Infectious Disease In Vitro Diagnostics Market - Germany
    • 9.4.7.1. Germany: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.7.2. Germany: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.7.3. Germany: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.7.4. Germany: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.8. Infectious Disease In Vitro Diagnostics Market - Italy
    • 9.4.8.1. Italy: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.8.2. Italy: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.8.3. Italy: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.8.4. Italy: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.9. Infectious Disease In Vitro Diagnostics Market - Spain
    • 9.4.9.1. Spain: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.9.2. Spain: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.9.3. Spain: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.9.4. Spain: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.10. Infectious Disease In Vitro Diagnostics Market - Netherlands
    • 9.4.10.1. Netherlands: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.10.2. Netherlands: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.10.3. Netherlands: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.10.4. Netherlands: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.4.11. Infectious Disease In Vitro Diagnostics Market - Russia
    • 9.4.11.1. Russia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.11.2. Russia.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.11.3. Russia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.4.11.4. Russia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• 9.5. Infectious Disease In Vitro Diagnostics Market - Asia Pacific
  • 9.5.1. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
  • 9.5.2. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 9.5.3. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
  • 9.5.4. Asia Pacific: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5.5. Infectious Disease In Vitro Diagnostics Market - China
    • 9.5.5.1. China: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.5.2. China.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.5.3. China: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.5.4. China: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5.6. Infectious Disease In Vitro Diagnostics Market - India
    • 9.5.6.1. India: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.6.2. India.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.6.3. India: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.6.4. India: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5.7. Infectious Disease In Vitro Diagnostics Market - Japan
    • 9.5.7.1. Japan: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.7.2. Japan.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.7.3. Japan: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.7.4. Japan: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5.8. Infectious Disease In Vitro Diagnostics Market - Malaysia
    • 9.5.8.1. Malaysia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.8.2. Malaysia.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.8.3. Malaysia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.8.4. Malaysia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5.9. Infectious Disease In Vitro Diagnostics Market - Indonesia
    • 9.5.9.1. Indonesia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.9.2. Indonesia.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.9.3. Indonesia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.9.4. Indonesia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.5.10. Infectious Disease In Vitro Diagnostics Market - South Korea
    • 9.5.10.1. South Korea: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.10.2. South Korea.: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.10.3. South Korea: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.5.10.4. South Korea: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• 9.6. Infectious Disease In Vitro Diagnostics Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
  • 9.6.2. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 9.6.3. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
  • 9.6.4. Middle East & Africa: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6.5. Infectious Disease In Vitro Diagnostics Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6.6. Infectious Disease In Vitro Diagnostics Market - South Africa
    • 9.6.6.1. South Africa: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.6.2. South Africa: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.6.6.3. South Africa: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.6.4. South Africa: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6.7. Infectious Disease In Vitro Diagnostics Market - Israel
    • 9.6.7.1. Israel: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.7.2. Israel: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.6.7.3. Israel: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.7.4. Israel: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.6.8. Infectious Disease In Vitro Diagnostics Market - UAE
    • 9.6.8.1. UAE: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.8.2. UAE: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.6.8.3. UAE: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.6.8.4. UAE: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
• 9.7. Infectious Disease In Vitro Diagnostics Market - Latin America
  • 9.7.1. Latin America: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
  • 9.7.2. Latin America: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 9.7.3. Latin America: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
  • 9.7.4. Latin America: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.7.5. Infectious Disease In Vitro Diagnostics Market - Mexico
    • 9.7.5.1. Mexico: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.5.2. Mexico: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.7.5.3. Mexico: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.7.5.4. Mexico: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.7.6. Infectious Disease In Vitro Diagnostics Market - Brazil
    • 9.7.6.1. Brazil: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.6.2. Brazil: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.7.6.3. Brazil: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.7.6.4. Brazil: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)
  • 9.7.7. Infectious Disease In Vitro Diagnostics Market - Argentina
    • 9.7.7.1. Argentina: Infectious Disease In Vitro Diagnostics Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.7.2. Argentina: Infectious Disease In Vitro Diagnostics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.7.7.3. Argentina: Infectious Disease In Vitro Diagnostics Market, by Product, 2018 - 2030 (USD Billion)
    • 9.7.7.4. Argentina: Infectious Disease In Vitro Diagnostics Market, by Technology, 2018 - 2030 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Becton Dickinson and Company
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Bio-Rad Laboratories, Inc
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Danaher Corporation
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. DiaSorin
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. F. Hoffmann-La Roche AG
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Hologic, Inc
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Illumina, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. InBios International, Inc
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Koninklijke Philips N.V
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Laboratory Corporation of America Holdings
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Merck KGaA
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. OraSure Technologies, Inc.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. PerkinElmer, Inc
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Qiagen N.V
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development
• 11.16. Quest Diagnostics
  • 11.16.1. Company Overview
  • 11.16.2. Financial Performance
  • 11.16.3. Product Benchmarking
  • 11.16.4. Recent Development
• 11.17. Quidel Corporation
  • 11.17.1. Company Overview
  • 11.17.2. Financial Performance
  • 11.17.3. Product Benchmarking
  • 11.17.4. Recent Development
• 11.18. Siemens Healthcare AG
  • 11.18.1. Company Overview
  • 11.18.2. Financial Performance
  • 11.18.3. Product Benchmarking
  • 11.18.4. Recent Development
• 11.19. Sysmex Corporation
  • 11.19.1. Company Overview
  • 11.19.2. Financial Performance
  • 11.19.3. Product Benchmarking
  • 11.19.4. Recent Development
• 11.20. Thermo Fisher Scientific Inc
  • 11.20.1. Company Overview
  • 11.20.2. Financial Performance
  • 11.20.3. Product Benchmarking
  • 11.20.4. Recent Development